CHALLENGE
A major pharmaceutical company’s oncology brand faced an unexpected challenge – three critical product label updates required within a nine-month period, all without additional funding. The accelerated timeline, combined with the need to maintain full regulatory and compliance alignment, placed intense pressure on internal teams and resources. Without careful coordination, the risk of missed deadlines, compliance breaches, and budget overruns was high.
SOLUTIONS
CMK Select partnered closely with the client’s Regulatory and Drug Regulatory Affairs (DRA) teams to develop a strategy to deliver an integrated, efficient execution plan. CMK consolidated timelines across all three label updates, ensuring alignment between Regulatory, Promotional Review (LMR), and Commercial functions. To optimize time and resources, CMK managed asset updates and LMR reviews, oversaw in-house print production to minimize costs, and coordinated digital asset updates across both internal and external agencies. By leveraging pre-approved messaging, CMK significantly reduced LMR review cycles – streamlining execution while maintaining quality and compliance across all assets.
-
3critical product label updates completed within 9-months
-
$0budget increase — all work completed within existing budget
-
100%compliance with Drug Regulatory Affairs (DRA) and Promotional Review (LMR) requirements
IMPACT & VALUE REALIZED
Through a combination of domain expertise, client partnership, and project management discipline, CMK delivered outstanding outcomes. All three product label updates were successfully implemented within nine months, with no increase in budget. The team achieved 100% compliance with DRA and LMR requirements, meeting or exceeding every deadline. This collaborative and strategic approach ensured the brand’s marketing materials were compliant and remained in-market, strengthened regulatory confidence, and demonstrated CMK’s ability to drive operational excellence under demanding conditions.